These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3167325)

  • 1. Pathology, phenomenology, and the dopamine hypothesis of schizophrenia.
    Kerwin RW
    Br J Psychiatry; 1988 Jan; 152():141-2. PubMed ID: 3167325
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology, phenomenology and the dopamine hypothesis of schizophrenia.
    McKenna PJ
    Br J Psychiatry; 1987 Sep; 151():288-301. PubMed ID: 3322465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine in schizophrenia and Parkinson's disease.
    Birtwistle J; Baldwin D
    Br J Nurs; 1998 Jul 23-Aug 12; 7(14):832-4, 836, 838-41. PubMed ID: 9849144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-acetylcholine interactions in the modulation of glutamate release.
    Atzori M; Kanold P; Pineda JC; Flores-Hernandez J
    Ann N Y Acad Sci; 2003 Nov; 1003():346-8. PubMed ID: 14684457
    [No Abstract]   [Full Text] [Related]  

  • 5. Schizophrenia and the brain at the 1984 winter workshop, Davos, Switzerland.
    Stevens JR
    Arch Gen Psychiatry; 1984 Aug; 41(8):816-7. PubMed ID: 6742981
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.
    Carlsson A; Waters N; Holm-Waters S; Tedroff J; Nilsson M; Carlsson ML
    Annu Rev Pharmacol Toxicol; 2001; 41():237-60. PubMed ID: 11264457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia.
    Reynolds GP
    Nature; 1983 Oct 6-12; 305(5934):527-9. PubMed ID: 6621699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On biology, phenomenology, and pharmacology in schizophrenia.
    Jones HM
    Am J Psychiatry; 2004 Feb; 161(2):376-7; author reply 377-8. PubMed ID: 14754797
    [No Abstract]   [Full Text] [Related]  

  • 9. On biology, phenomenology, and pharmacology in schizophrenia.
    Gray JA
    Am J Psychiatry; 2004 Feb; 161(2):377; author reply 377-8. PubMed ID: 14754801
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On biology, phenomenology, and pharmacology in schizophrenia.
    Crane DL
    Am J Psychiatry; 2004 Feb; 161(2):376; author reply 377-8. PubMed ID: 14754798
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine in schizophrenia.
    Heritch AJ
    Am J Psychiatry; 1992 Nov; 149(11):1620-1. PubMed ID: 1415847
    [No Abstract]   [Full Text] [Related]  

  • 14. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.
    Jentsch JD; Roth RH
    Neuropsychopharmacology; 1999 Mar; 20(3):201-25. PubMed ID: 10063482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical approach to schizophrenia].
    Lipcsey A
    Orv Hetil; 1980 Nov; 121(47):2863-70. PubMed ID: 7219990
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process.
    Crow TJ; Johnstone EC; Longden AJ; Owen F
    Life Sci; 1978 Aug; 23(6):563-7. PubMed ID: 29195
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
    Seeman P; Ulpian C; Bergeron C; Riederer P; Jellinger K; Gabriel E; Reynolds GP; Tourtellotte WW
    Science; 1984 Aug; 225(4663):728-31. PubMed ID: 6147018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability and the dopamine hypothesis of schizophrenia.
    Csernansky JG; Holman CA; Hollister LE
    Schizophr Bull; 1983; 9(3):325-8. PubMed ID: 6622990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for schizophrenia--all roads lead to dopamine.
    Di Forti M; Lappin JM; Murray RM
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S101-7. PubMed ID: 17336764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.